Serum osteocalcin levels in patients with GH deficiency before and during GH treatment.
Sartorio
A
A
Istituto di Scienze Endocrine, Ospedale Policlinico, Padiglione Sacco, Milano, Italy.
Conti
A
A
Guzzaloni
G
G
Faglia
G
G
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006128:Growth / Q000502:physiology; D006130:Growth Disorders / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D013006:Growth Hormone / Q000031:analogs & derivatives* / Q000172:deficiency* / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use*; D019382:Human Growth Hormone; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008297:Male; D015675:Osteocalcin / Q000097:blood*; D011994:Recombinant Proteins / Q000627:therapeutic use
D006728:Hormones; D011994:Recombinant Proteins; D015675:Osteocalcin; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone